Exploration of the Pharmacophore for Cytoskeletal Targeting Ruthenium Polypyridyl Complexes

Area of Science:

• Coordination Chemistry
• Chemical Biology
• Materials Science

Background:

• Ruthenium(II) trisdiimine complexes are investigated for their potential biological applications.
• Understanding the relationship between structure, lipophilicity, and biological activity is crucial for drug development.

Purpose of the Study:

• To synthesize and characterize Ruthenium(II) trisdiimine complexes.
• To evaluate their cytotoxicity, cellular uptake, and subcellular localization.
• To determine the role of lipophilicity and structural features in their biological effects.

Main Methods:

• Synthesis of [Ru(dip)n(L-L)3-n]2+ complexes (n=0-3).
• Cytotoxicity assays on H358 and MCF7 cell lines.
• Cellular uptake and subcellular fractionation using Ru ICP-MS.
• Measurement of logP values for lipophilicity assessment.
• In vitro tubulin polymerization assays.

Main Results:

• Cellular uptake and cytotoxicity increased with complex lipophilicity, particularly with two or more dip ligands.
• Preferential localization to the cytoskeleton correlated with increased cytotoxicity.
• [Ru(dip)2phen]2+ and [Ru(dip)3]2+ demonstrated potent tubulin polymerization activity.
• A 1:1 binding stoichiometry of Ruthenium complexes to tubulin heterodimers was observed.

Conclusions:

• Ruthenium complexes with enhanced lipophilicity and cytoskeletal targeting ability show significant cytotoxicity.
• The dip ligand plays a key role in promoting tubulin polymerization and anti-cancer effects.
• Further development of these complexes could lead to novel anti-cancer agents.